Skip to main content
. Author manuscript; available in PMC: 2010 Mar 30.
Published in final edited form as: Risk Anal. 2008 Sep 26;29(1):121–136. doi: 10.1111/j.1539-6924.2008.01135.x

Table II.

Treatment Attributes and Levels

Treatment Attribute Levels
Symptoms and activity limitations
  • Remission:
    • - No pain most days
    • - No more than 1 loose stool per day
    • - Generally feel well
    • - No problems with work or leisure activities
  • Mild Crohn's disease:
    • - Mild pain most days
    • - About 3 diarrhea stools per day
    • - Generally feel below par
    • - Some problems with work and leisure activities
  • Moderate Crohn's disease:
    • - Moderate pain most days or severe pain on some days
    • - About 8 or more diarrhea stools per day
    • - Generally feel poorly
    • - Considerable problems with work and leisure activities
  • Severe Crohn's disease:
    • - Severe pain most days
    • - More than 12 diarrhea stools per day
    • - Generally feel terrible
    • - Unable to engage in work and leisure activities
Serious complications from CD
  • Treatment prevents all serious complications of CD

  • Treatment reduces some of the serious complications of CD

  • Treatment has no effect on the serious complications of CD

Time between flare-ups
  • 6 months between flare-ups

  • 2 years between flare-ups

Need to take oral steroids
  • Requires taking steroids

  • Does not require taking steroids

Chance of dying from serious infection within 10 years
  • None would die

  • 5 patients out of 1,000 (0.5%) would die

  • 20 patients out of 1,000 (2.0%) would die

  • 50 patients out of 1,000 (5.0%) would die

Chance of dying or severe disability from PML within 10 years
  • None would die or have disability

  • 5 patients out of 1,000 (0.5%) would die or have disability

  • 20 patients out of 1,000 (2.0%) would die or have disability

  • 50 patients out of 1,000 (5.0%) would die or have disability

Chance of dying from lymphoma within 10 years
  • None would die

  • 5 patients out of 1,000 (0.5%) would die

  • 20 patients out of 1,000 (2.0%) would die

  • 50 patients out of 1,000 (5.0%) would die